AAAAAA
Results:
1-15
|
Results: 15
Authors:
Bolli, GB
Citation: Gb. Bolli, Physiological insulin replacement in type 1 diabetes mellitus, EXP CL E D, 109, 2001, pp. S317-S332
Authors:
Owens, DR
Zinman, B
Bolli, GB
Citation: Dr. Owens et al., Insulins today and beyond, LANCET, 358(9283), 2001, pp. 739-746
Authors:
Bolli, GB
Owens, DR
Citation: Gb. Bolli et Dr. Owens, Insulin glargine, LANCET, 356(9228), 2000, pp. 443-445
Authors:
Falorni, A
Gambelunghe, G
Forini, F
Kassi, G
Cosentino, A
Candeloro, P
Bolli, GB
Brunetti, P
Calcinaro, F
Citation: A. Falorni et al., Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the riskfor insulin requirement in adult-onset diabetes mellitus, J CLIN END, 85(1), 2000, pp. 309-316
Authors:
Nuutila, P
Peltoniemi, P
Oikonen, V
Larmola, K
Kemppainen, J
Takala, T
Sipila, H
Oksanen, A
Ruotsalainen, U
Bolli, GB
Yki-Jarvinen, H
Citation: P. Nuutila et al., Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans - Studies using [O-15]O-2, [O-15]H2O, [F-18]fluoro-deoxy-glucose and positron emission tomography, DIABETES, 49(7), 2000, pp. 1084-1091
Authors:
Lepore, M
Pampanelli, S
Fanelli, C
Porcellati, F
Bartocci, L
Di Vincenzo, A
Cordoni, C
Costa, E
Brunetti, P
Bolli, GB
Citation: M. Lepore et al., Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro, DIABETES, 49(12), 2000, pp. 2142-2148
Authors:
Brunetti, P
Bolli, GB
Citation: P. Brunetti et Gb. Bolli, Intensive insulin therapy in type 1 diabetes, DIABETES IN THE NEW MILLENNIUM, 2000, pp. 65-80
Authors:
Bolli, GB
Fanelli, CG
Citation: Gb. Bolli et Cg. Fanelli, Physiology of glucose counterregulation to hypoglycemia, END METAB C, 28(3), 1999, pp. 467
Authors:
Bolli, GB
Citation: Gb. Bolli, Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus, J PED END M, 12, 1999, pp. 737-744
Authors:
Ciofetta, M
Lalli, C
Del Sindaco, P
Torlone, E
Pampanelli, S
Mauro, L
Chiara, D
Brunetti, P
Bolli, GB
Citation: M. Ciofetta et al., Contribution of postprandial versus interprandial blood glucose to HbA(1c)in type 1 diabetes on physiologic intensive therapy with lispro insulin atmealtime, DIABET CARE, 22(5), 1999, pp. 795-800
Authors:
Lalli, C
Ciofetta, M
del Sindaco, P
Torlone, E
Pampanelli, S
Compagnucci, P
Cartechini, MG
Bartocci, L
Brunetti, P
Bolli, GB
Citation: C. Lalli et al., Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime, DIABET CARE, 22(3), 1999, pp. 468-477
Authors:
Bolli, GB
Di Marchi, RD
Park, GD
Pramming, S
Koivisto, VA
Citation: Gb. Bolli et al., Insulin analogues and their potential in the management of diabetes mellitus, DIABETOLOG, 42(10), 1999, pp. 1151-1167
Authors:
Bolli, GB
Citation: Gb. Bolli, Prevention and treatment of hypoglycaemia unawareness in type 1 diabetes mellitus, ACT DIABETO, 35(4), 1998, pp. 183-193
Authors:
Jansson, PA
Ebeling, P
Smith, U
Conget, I
Coves, VJ
Gomis, R
Lalli, C
Del Sindaco, P
Bolli, GB
Koivisto, VA
Citation: Pa. Jansson et al., Improved glycemic control can be better maintained with insulin lispro than with human regular insulin, DIABET NUTR, 11(3), 1998, pp. 194-199
Authors:
Volpi, E
Lucidi, P
Bolli, GB
Santeusanio, F
De Feo, P
Citation: E. Volpi et al., Gender differences in basal protein kinetics in young adults, J CLIN END, 83(12), 1998, pp. 4363-4367
Risultati:
1-15
|